Overview

Company Name
Modalis Therapeutics Corporation
Foundation
January 2016
Representative Directors
Haru Morita
Headquarters
3-11-5 Nihonbashi-Honcho, Nihonbashi-Lifescience-Bldg.2 7F Chuo-ku, Tokyo,103-0023 JAPAN
U.S. Office R&D Operations
Modalis Therapeutics Inc.
(43 Foundry Avenue, Waltham, Massachusetts, 02453 USA)
※ The research laboratory of Modalis has relocated as of October 20, 2021.
Scope of Business
Drug development
Number of Employees

23 (as of June 30, 2021, consolidated)

MODALIS

Modalis (pronounced “MO-DA-LIS”) is an original name that the Company has chosen to hope Company’s proprietary gene modulation technology, CRISPR-GNDM, to be a new modality (therapeutic technology) to assist patients fighting with genetic disorders. It is the key to treatment of genetic diseases, and the logo of the company name expresses “a gene switch” becoming the target of the CRISPR-GNDM®︎ technology.

MODALIS